Akari Therapeutics PLC (AKTX): Qarzning balans kapitallashuviga nisbati
Akari Therapeutics (AKTX) kompaniyasining kredit profili noyob patologiyalarga yo'naltirilgan klinik tadqiqotlar uchun investitsiya moliyalashtirilganiga asoslangan. Balansning kapital tuzilmasi risk metriklari narxlar barqarorligini namoyish etmoqda, shu bilan birga 0.04 darajasi yangi qiymatlarni qayd etmoqda. Resurslar bazasi biofarmatsevtika sektoridagi strategik birlashmalarga tayanadi, ishlab chiqarish quvvati esa biologik mahsulotlar chiqarish uchun kontrakt ishlab chiqarish maydonlarining texnik modernizatsiyasi bilan ta'minlanadi.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_AKTX_-_Akari-Therapeutics_-_Debt-to-Net-Assets-Ratio "AKTX: Akari Therapeutics Qarzning balans kapitallashuviga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
Akari Therapeutics PLC (AKTX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Akari Therapeutics|AKTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Akari Therapeutics plc|AKTX - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Akari Therapeutics, Plc|AKTX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Akari Therapeutics
Kompaniyaning har tomonlama tahlili:AKTX (Akari Therapeutics)
Akari Therapeutics (AKTX) noyob immun patologiyalarini davolovchi dori vositalari uchun klinik sinovlarga e'tibor qaratadi va hozirda hech qanday daromad keltirmaydi. Operatsion pul oqimining yo'qligi baholash modelini kapitaldagi o'zgarishlarga sezgir qiladi. Ushbu ko'rsatkich biznesning sof aktivlariga nisbatan qarz mablag'lariga bog'liqligini o'lchaydi va bu tebranishlar davrida emitentning moliyaviy barqarorligini aniqlash imkonini beradi. Kompaniyaning qarzning kitob qiymatidagi kapitalizatsiya ko'rsatkichini tahlil qilish orqali investor aktiv haddan tashqari qimmat baholanganmi yoki fundamental jihatdan past baholanganmi, shuni aniqlashi mumkin.
Akari Therapeutics (AKTX) raqobatchilari
Balans kapitallashuviga qarzlar ARGX (argenx SE)|Balans kapitallashuviga qarzlar biontech.de BNTX|ABVX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ADMA (ADMA Biologics Inc)|Protagonist Therapeutics Inc (PTGX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Immunovant Therapeutics|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com|Qarzning balans qiymatiga nisbati ADPT (Adaptive Biotechnologies Corporation)|CLDX (Celldex Therapeutics Inc) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AUPH (Aurinia Pharma)|Sof aktivlarga qarzlar BioCryst Corp (BCRX)|VERA - Qarzning balans kapitallashuviga nisbati|dianthustx.com (DNTH) - Qarzning balans qiymatiga nisbati|Pharvaris (PHVS) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|Qarzning balans qiymatiga nisbati TRML|Balans kapitallashuviga qarzlar Precigen Corp|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. (PHAR)|nektar.com - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar UPB (Upstream Bio)|Zenas Bio (ZBIO) - Balans qiymatiga qarzlar|Immunome Corp - Balans kapitallashuviga qarzlar|GOSS - Balans kapitallashuviga qarzlar|KalVista Pharmaceuticals (KALV) - Qarzning balans kapitallashuviga nisbati|septerna.com (SEPN) - Balans kapitallashuviga qarzlar|PVLA (Pieris Pharmaceuticals, Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Savara Inc|Qarzning balans kapitallashuviga nisbati Rigel Pharmaceuticals Inc (RIGL)|ANAB (AnaptysBio Inc.) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ATXS (Astria Therapeutics)|Sof aktivlarga qarzlar engene.com (ENGN)|RAPT: Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris) - Qarzning balans qiymatiga nisbati|KYTX: Qarzning balans kapitaliga nisbati|TLSA (Tiziana Life Sciences) - Balans kapitallashuviga qarzlar|CABA: Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar VTYX|THTX - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Avalo Therapeutics Inc. AVTX|Qarzning sof aktivlarga nisbati ELDN|Agenus - Balans kapitallashuviga qarzlar|CLYM - Balans kapitallashuviga qarzlar|Zura Bio Limited (ZURA) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati ATYR (aTyr Pharma Inc)|ADAG (Adagene Inc) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Ikena Oncology, Inc. IMA|Qarzning balans qiymatiga nisbati STTK (Shattuck Labs, Inc.)|Balans kapitallashuviga qarzlar equilliumbio.com (EQ)|Connect Biopharma Holdings Limited - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati IMUX (Immunic Therapeutics)|Atara Biotherapeutics Inc - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar InflaRx N.V. IFRX|XFOR: Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Adicet Bio, Inc.|Qarzning balans kapitallashuviga nisbati Celularity Inc|INmune Bio Inc (INMB) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar BRNS|Balans kapitallashuviga qarzlar Kezar Life Sciences Inc (KZR)|Qarzning balans kapitallashuviga nisbati SAB Biotherapeutics SABS|Balans kapitallashuviga qarzlar Enlivex Therapeutics Ltd ENLV|QTTB: Qarzning balans qiymatiga nisbati|GeoVax Labs - Qarzning balans kapitaliga nisbati|EDSA (Edesa) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati IBIO|Qarzning balans kapitallashuviga nisbati Carisma Therapeutics Inc|xtlbio.com - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar BOLT|HCWB (hcwbiologics.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar APVO (Aptevo Therapeutics Inc.)|Balans kapitallashuviga qarzlar AIM ImmunoTech, Inc. AIM|ADTX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati GRI (gribio.com)|XORTX Therapeutics (XRTX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Vyome Holdings Inc.|REVB (Revelation Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Indaptus Corp|Qarzning balans qiymatiga nisbati SCNI (Scinai Immunotherapeutics)|CALI (calcimedica.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AFMD (Affimed N.V.)|Sof aktivlarga qarzlar Allakos Inc (ALLK)|HOOK - Qarzning balans kapitallashuviga nisbati|IGM Biosciences, Inc. (IGMS) - Qarzning balans qiymatiga nisbati|iTeos Therapeutics (ITOS) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati oceanbiomedical.com|Qarzning balans qiymatiga nisbati TCBP|Balans kapitallashuviga qarzlar Third Harmonic Bio Inc.